The Miami Entrepreneur

J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance

Read Time:9 Second

When asked about halting guidance for J&J’s Covid vaccine, CFO Joe Wolk said the shots are not for profit and do not impact the company’s bottom line.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Bank of America shares jump after lender tops analysts’ estimates on better-than-expected credit
Next post U.S. commits to ending anti-satellite missile testing, calls for global agreement